Corteva, Inc. Q3 2025 Earnings Recap

Corteva Agriscience reported strong third-quarter results characterized by double-digit EBITDA growth, driven by robust performance in both its Seed and Crop Protection segments, alongside a proactive strategy to separate into two public companies.

Key Takeaways

• Third-quarter operating EBITDA rose by 14% year-over-year, with the company raising its full-year EBITDA guidance to a range of $3.8 billion to $3.9 billion.
• The Seed business achieved $200 million in productivity benefits and is on track to achieve double-digit trade penetration for Conkesta in Brazil.
• The Crop Protection segment anticipates high single-digit EBITDA growth for the year, supported by demand for differentiated technologies and the launch of the new insecticide Varpelgo.
• Corteva expects to deliver over $600 million in controllable benefits for 2025, up from a prior estimate of $530 million.
• The planned separation into two public companies is expected to enhance growth potential for the Seed and Crop Protection units, with a target completion set for the second half of 2026.